Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussion could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary and Alternative Medicine.
Date: May 5, 2009.
Closed: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications and/or proposals.
Place: National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892 (Teleconference).
Contact Person: Martin H. Goldrosen, PhD, Executive Secretary, Director, Division of Extramural Activities, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594-2014.
This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.Start Signature
Dated: April 22, 2009.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9681 Filed 4-27-09; 8:45 am]
BILLING CODE 4140-01-P